Therefore, this study compared the effectiveness of serum creatinine or serum cystatin C measures in estimating eGFR at different time intervals, to predict renal function decline (including proteinuria), among those with a recent eGFR of 30–89 ml/min/1.73 m2 (CKD stages 2 and 3). The gene discussed is CST3; the disease is chronic kidney disease.